ISRCTN35624812已完成未知
Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial
niversity of Calgary (Canada)0 个研究点目标入组 500 人开始时间: 2005年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
- 2007 results in https://www.ncbi.nlm.nih.gov/pubmed/17931979 (added 25/01/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients with TIA or minor acute ischemic stroke (National Institutes of Health Stroke Scale [NIHSS] equalling 3 at the time of randomisation) who must not be candidates for acute thrombolytic or anticoagulant therapy within 12 hours of symptom onset
- •2. Aged 40 years or over, either sex
- •3. Patients with:
- •3.1. Weakness at time of TIA/minor stroke and/or language disturbance at time of TIA/minor stroke
- •3.2. Duration of neurological deficit (TIA) equals 5 minutes
- •4. Patients can be randomised within 12 hours of symptom onset. Symptom onset is defined by the 'last seen well' principle
排除标准
- •1. Patients with pure sensory symptoms, pure vertigo or dizziness, or pure visual loss
- •2. Patients for whom thrombolysis or other acute intervention is indicated as the current standard of care
- •3. Patients who are currently on statin therapy, antiplatelet therapy (not including aspirin), or long-term Non-Steroidal Anti-Inflammatory Drugs (NSAIDs, but not COX inhibitors), or anticoagulation
- •4. Patients, who in the opinion of the site Investigator, should be commenced on statin therapy
- •5. Patients with neurological deficit due to intracranial hemorrhage (intracerebral hemorrhage, subarachnoid hemorrhage, subdural hematoma, epidural hematoma), tumor, infection or any finding not consistent with acute brain ischemia as the cause of presenting symptoms
- •6. Presumed cardiac source of embolus (e.g. atrial fibrillation, prosthetic cardiac valve, known/suspected endocarditis)
- •7. Patient with a concomitant acute coronary syndrome (acute myocardial infarction or unstable angina)
- •8. Modified Rankin Score of 3 or more (pre-morbid historical assessment)
- •9. Patients in whom the qualifying event was due to a complication of cerebral angiography, a revascularization procedure or trauma
- •10. Uncontrolled hypertension at baseline (systolic blood pressure greater than 180 mmHg or diastolic blood pressure greater than 110 mmHg), or malignant hypertension defined by brain plus other acute organ involvement due to acute hypertension
- •11. Women who are breast-feeding or pregnant. Women of childbearing potential must have a negative pregnancy test prior to randomization. Women of childbearing potential may still participate in the trial but must plan on not becoming pregnant during the course of the study and must practice a suitable method of birth control. If a patient becomes pregnant or begins breast-feeding during the study, both study drugs will be discontinued immediately, and the patient followed for the duration of the study
- •12. Evidence of contraindication for use of Trial Medication:
- •12.1. Current or past history of severe renal insufficiency
- •12.2. Current or past history of severe hepatic dysfunction
- •12.3. Current or past history of thrombocytopenia
- •12.4. Current or past history of neutropenia
- •12.5. Current or past history of bleeding diathesis or coagulopathy
- •12.6. Current or past history of serious systemic bleeding
- •12.7. Past History of hypersensitivity to aspirin, thienopyridine drugs (clopidogrel or ticlopidine) or statins
- •13. Life expectancy of less than 90 days
- •14. Geographical or other factors that render follow-up impractical or that render evaluation of outcome events impossible (e.g. severe dementia). Patients may be randomised who could and are willing to complete their follow-up at another participating centre
- •15. Participation in another clinical therapeutic trial (drug or device) either concurrently or within the previous 30 days, or prior participation in FASTER
研究者
相似试验
已完成
2 期
Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)StrokeTransient Ischemic AttackNCT00109382University of Calgary500
招募中
不适用
Point of care assessment in acute ischemic stroke with intravenous thrombolysis and/or history of direct oral anticoagulation medication – a prospective observational studyI64Stroke, not specified as haemorrhage or infarctionDRKS00028597niversitätsklinikum Carl Gustav CarusKlinik und Poliklinik für Anästhesiologie und Intensivtherapie1,850
招募中
不适用
A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting BridgeBrain DiseaseVertebral Artery StenosisNCT06301776The Fourth Affiliated Hospital of China Medical University560
已完成
不适用
Stroke and Traumatic Acute Brain Injury Line Indicator System for Emergent Recognition (STABILISER-I)Ischemic StrokeHemorrhagic StrokeTraumatic Brain InjuryNCT02514902Justin Fraser48
已完成
不适用
Identification of Stroke at the Emergency Medical Dispatch CenterStrokeNCT04784936Karolinska Institutet179